Designwerk provides mobile fast chargers for Nissan EV shuttle fleet; BRUSA NLG6
Navigant ranks LG Chem and Samsung SDI as top Li-ion grid storage manufacturers

Verdezyne secures distribution agreement for biobased dodecanedioic acid in Europe; 25% off-take

Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, reached an agreement with Will & Co, a sales and marketing firm for raw materials, semi-finished products, additives, and pigments, for distribution of Verdezyne’s first commercial product: BIOLON DDDA (biobased dodecanedioic acid or “DC12”) in Europe, one of the world’s largest chemical markets. BIOLON DDDA will be produced at Verdezyne’s commercial-scale plant in Malaysia. The agreement secures off-take for over 25% of the expected plant capacity.

Verdezyne’s BIOLON DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make engineering polymer resins, automotive parts, toothbrush bristles, cosmetics, fragrances, and more.

Verdezyne’s plant, expected to open in 2017, is anticipated to have the capacity to produce more than 10,000 metric tons of diacids annually, including BIOLON DDDA, drawing on Malaysia’s diverse and abundant base of plant-derived feedstocks.

Verdezyne has developed a highly-proprietary platform for engineering yeast to metabolize multiple non-food-based renewable feedstocks and produce a number of widely-used, high-value chemicals.

Comments

The comments to this entry are closed.